Elstar universal targeted immunotherapy

Elstar Therapeutics is fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating antibody-based, multi-functional therapeutics.

Armed with a unique approach to engaging multiple immune mechanisms, we enable patients to harness their own body to fight cancer.

Our Universal Targeted Immunotherapy (UniTI™) platform positions us to overcome barriers that have limited the full potential of other promising immunotherapeutic approaches.

“Our motivation…to be part of the cure for cancer”


Elstar is funded by Apple Tree Partners


Intrigued by our approach? Contact Elstar Therapeutics to learn how our companies can work together.